Pacira BioSciences, Inc.

PCRX

Reporting person: DOMA(group)

DOMA challenges Pacira board with slate of three director nominees

Contested meetingmedium confidence

Contest Strategydissident slate, solicitors, demands

Contested annual

What's being contested

Board seats

IssuerPacira BioSciences, Inc. (PCRX)

Issuer solicitor—

Reporting personDOMA (group)

Dissident solicitorD.F. King & Co., Inc.

Stake—

Dissident counsel—

Cost basis—

Meeting date—

Record date—

Dissident slate (3)

Oliver Benton Curtis III
Eric de Armas
Christopher Dennis

Primary demands

board refreshment
director election

Advisors

No advisor data on record for this deal.

Sources

SEC Filing

This is a preliminary proxy statement (PREC14A) filed by DOMA (Dissident Ownership Management Association or similar entity) opposing Pacira BioSciences' management slate in a contested 2026 Annual Meeting. DOMA is nominating three director candidates (Oliver Benton Curtis III, Eric de Armas, and Christopher Dennis) in opposition to the company's recommended nominees (Christopher J. Christie, Samit Hirawat, and Tom Wiggans). The filing solicits votes for the DOMA slate on the BLUE universal proxy card while the company recommends withholding votes for the DOMA nominees.

Item id: 3af7d8da-96f0-4bc7-b056-6548595dd85c · ingested Apr 24, 2026